These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 1922031

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression.
    Musgrove EA, Hamilton JA, Lee CS, Sweeney KJ, Watts CK, Sutherland RL.
    Mol Cell Biol; 1993 Jun; 13(6):3577-87. PubMed ID: 8497271
    [Abstract] [Full Text] [Related]

  • 3. Effects of the progestin antagonist RU 486 on T-47D breast cancer cell cycle kinetics and cell cycle regulatory genes.
    Musgrove EA, Sutherland RL.
    Biochem Biophys Res Commun; 1993 Sep 30; 195(3):1184-90. PubMed ID: 8216247
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor.
    McGowan EM, Russell AJ, Boonyaratanakornkit V, Saunders DN, Lehrbach GM, Sergio CM, Musgrove EA, Edwards DP, Sutherland RL.
    Cancer Res; 2007 Sep 15; 67(18):8942-51. PubMed ID: 17875737
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucocorticoids induce a G1/G0 cell cycle arrest of Con8 rat mammary tumor cells that is synchronously reversed by steroid withdrawal or addition of transforming growth factor-alpha.
    Goya L, Maiyar AC, Ge Y, Firestone GL.
    Mol Endocrinol; 1993 Sep 15; 7(9):1121-32. PubMed ID: 8247014
    [Abstract] [Full Text] [Related]

  • 9. Modulation of the growth-inhibitory effects of progestins and the antiestrogen hydroxyclomiphene on human breast cancer cells by epidermal growth factor and insulin.
    Koga M, Musgrove EA, Sutherland RL.
    Cancer Res; 1989 Jan 01; 49(1):112-6. PubMed ID: 2642286
    [Abstract] [Full Text] [Related]

  • 10. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V, Miodini P, Fioravanti L, Di Fronzo G.
    Anticancer Res; 1995 Jan 01; 15(6B):2551-5. PubMed ID: 8669822
    [Abstract] [Full Text] [Related]

  • 11. Regulation of breast cancer cell cycle progression by growth factors, steroids and steroid antagonists.
    Sutherland RL, Lee CS, Feldman RS, Musgrove EA.
    J Steroid Biochem Mol Biol; 1992 Mar 01; 41(3-8):315-21. PubMed ID: 1562509
    [Abstract] [Full Text] [Related]

  • 12. Regulation of epidermal growth factor receptor by progestins and glucocorticoids in human breast cancer cell lines.
    Ewing TM, Murphy LJ, Ng ML, Pang GY, Lee CS, Watts CK, Sutherland RL.
    Int J Cancer; 1989 Oct 15; 44(4):744-52. PubMed ID: 2793247
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.